Birchview Capital as of Dec. 31, 2019
Portfolio Holdings for Birchview Capital
Birchview Capital holds 52 positions in its portfolio as reported in the December 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol Myers Squibb (BMY) | 36.3 | $50M | 779k | 64.19 | |
Accelr8 Technology | 26.8 | $37M | 2.2M | 16.90 | |
Neurocrine Biosciences (NBIX) | 4.3 | $5.9M | 55k | 107.49 | |
Quidel Corporation | 2.7 | $3.7M | 49k | 75.03 | |
Oxford Immunotec Global | 2.0 | $2.8M | 170k | 16.60 | |
Vermillion | 1.9 | $2.6M | 3.2M | 0.81 | |
Rts/bristol-myers Squibb Compa | 1.5 | $2.1M | 700k | 3.01 | |
Contrafect | 1.3 | $1.8M | 2.8M | 0.62 | |
Eqt Midstream Partners | 1.1 | $1.5M | 51k | 29.97 | |
Karyopharm Therapeutics (KPTI) | 1.1 | $1.5M | 80k | 19.18 | |
Soleno Therapeutics | 1.1 | $1.5M | 511k | 2.94 | |
Biogen Idec (BIIB) | 1.1 | $1.5M | 5.0k | 296.80 | |
Harrow Health (HROW) | 1.0 | $1.4M | 180k | 7.78 | |
Vanda Pharmaceuticals (VNDA) | 0.9 | $1.3M | 80k | 16.41 | |
Masimo Corporation (MASI) | 0.9 | $1.3M | 8.0k | 158.00 | |
Amarin Corporation (AMRN) | 0.9 | $1.3M | 59k | 21.44 | |
Arvinas Ord (ARVN) | 0.9 | $1.2M | 30k | 41.10 | |
Albireo Pharma | 0.9 | $1.2M | 48k | 25.42 | |
Dermira | 0.9 | $1.2M | 80k | 15.16 | |
G1 Therapeutics (GTHX) | 0.8 | $1.1M | 40k | 26.42 | |
Intercept Pharmaceuticals In | 0.8 | $1.0M | 8.3k | 123.98 | |
Arena Pharmaceuticals | 0.7 | $999k | 22k | 45.41 | |
Chemocentryx | 0.7 | $989k | 25k | 39.56 | |
Acceleron Pharma | 0.7 | $990k | 19k | 53.02 | |
ImmunoGen | 0.7 | $920k | 180k | 5.11 | |
Wright Medical | 0.7 | $914k | 30k | 30.47 | |
Myriad Genetics (MYGN) | 0.6 | $817k | 30k | 27.23 | |
Qiagen Nv | 0.5 | $676k | 20k | 33.80 | |
Odonate Therapeutics Ord | 0.5 | $649k | 20k | 32.45 | |
Corcept Therapeutics Incorporated (CORT) | 0.4 | $605k | 50k | 12.10 | |
ACADIA Pharmaceuticals (ACAD) | 0.4 | $599k | 14k | 42.79 | |
Pioneer Natural Resources (PXD) | 0.4 | $575k | 3.8k | 151.32 | |
Biohaven Pharmaceutical Holding | 0.4 | $544k | 10k | 54.40 | |
Kalvista Pharmaceuticals (KALV) | 0.4 | $534k | 30k | 17.80 | |
Gossamer Bio (GOSS) | 0.3 | $469k | 30k | 15.63 | |
United Therapeutics Corporation (UTHR) | 0.3 | $440k | 5.0k | 88.00 | |
Xencor (XNCR) | 0.3 | $423k | 12k | 34.39 | |
Voyager Therapeutics (VYGR) | 0.3 | $419k | 30k | 13.97 | |
Progyny (PGNY) | 0.3 | $412k | 15k | 27.47 | |
Amicus Therapeutics (FOLD) | 0.3 | $370k | 38k | 9.74 | |
Sientra | 0.3 | $358k | 40k | 8.95 | |
Lexicon Pharmaceuticals (LXRX) | 0.2 | $332k | 80k | 4.15 | |
Veracyte (VCYT) | 0.2 | $301k | 11k | 27.96 | |
Apellis Pharmaceuticals (APLS) | 0.2 | $245k | 8.0k | 30.62 | |
Encana Corp | 0.2 | $232k | 50k | 4.68 | |
Dicerna Pharmaceuticals | 0.2 | $220k | 10k | 22.00 | |
Continental Resources | 0.1 | $206k | 6.0k | 34.33 | |
Tg Therapeutics (TGTX) | 0.1 | $167k | 15k | 11.13 | |
Yield10 Bioscience | 0.1 | $129k | 758k | 0.17 | |
Workhorse Group Inc ordinary shares (WKHS) | 0.1 | $76k | 25k | 3.04 | |
Livent Corp | 0.1 | $86k | 10k | 8.60 | |
BioCryst Pharmaceuticals (BCRX) | 0.1 | $69k | 20k | 3.45 |